Skip to content

OVALITH-300 Implantable Pacemaker Pulse-Generator

by Coratomic, Inc.

510(k) K790446

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK790446 Date30 Jul 1979ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Ovalith-300
510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Ovalith-300 is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when spontaneous contractions are insufficient. It is intended for patients with bradycardia or other conduction disorders requiring chronic cardiac pacing.

This device is supplied as a reusable, implantable component and is regulated under FDA 510(k) clearance (K790446) as a substantially equivalent device to prior generations. It is classified under regulation number 870.3610 and falls under the Cardiovascular specialty category, adhering to strict manufacturing and sterility standards for implantable electronics. No additional context on MRI safety, single-use status, or specific storage requirements is provided in the available data.

Other devices from Coratomic, Inc.

See all devices from Coratomic, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is the Ovalith-300 designed for single-use or can it be reused after implantation?

    The Ovalith-300 is explicitly described as a reusable, implantable component. Since it is intended for long-term cardiac pacing and classified under FDA regulation 870.3610 for implantable electronics, it is not a single-use device. Reuse is permitted as part of its design and regulatory pathway, though proper sterilization and handling protocols must be followed per manufacturer guidelines.

  • What types of heart conditions is the Ovalith-300 approved to treat, and how does it work?

    The Ovalith-300 is intended for patients with bradycardia or conduction disorders requiring chronic cardiac pacing. It works by delivering electrical impulses to the heart muscle when the heart’s natural contractions are insufficient, thereby regulating heart rhythm. This is a standard function of implantable pacemaker pulse-generators, and the device’s approval reflects its role in managing these specific cardiac conditions.

  • How is the Ovalith-300 regulated by the FDA, and what does its classification mean for clinicians?

    The Ovalith-300 is a Class III medical device regulated under FDA 510(k) clearance (K790446) and falls under regulation number 870.3610. This classification means it is subject to strict manufacturing and sterility standards, as it is an implantable electronic device. The device was deemed substantially equivalent to prior generations, ensuring it meets existing safety and performance criteria for pacemaker pulse-generators.

  • Does the Ovalith-300 come with any specific storage requirements, and is it sterile upon receipt?

    The provided data does not explicitly detail storage requirements or sterility status for the Ovalith-300. However, as an implantable device regulated under FDA standards for electronics, it must adhere to strict manufacturing protocols to ensure sterility before use. Clinicians should follow the manufacturer’s instructions for handling, storage, and preparation to maintain device integrity and patient safety.